BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 25768874)

  • 21. World Health Organization Guidelines for treatment of cervical intraepithelial neoplasia 2-3 and screen-and-treat strategies to prevent cervical cancer.
    Santesso N; Mustafa RA; Schünemann HJ; Arbyn M; Blumenthal PD; Cain J; Chirenje M; Denny L; De Vuyst H; Eckert LO; Forhan SE; Franco EL; Gage JC; Garcia F; Herrero R; Jeronimo J; Lu ER; Luciani S; Quek SC; Sankaranarayanan R; Tsu V; Broutet N;
    Int J Gynaecol Obstet; 2016 Mar; 132(3):252-8. PubMed ID: 26868062
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evaluation of Cervical Cancer Screening Programs in Côte d'Ivoire, Guyana, and Tanzania: Effect of HIV Status.
    Anderson J; Wysong M; Estep D; Besana G; Kibwana S; Varallo J; Sun K; Lu E
    PLoS One; 2015; 10(9):e0139242. PubMed ID: 26405784
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Residual or Recurrent Precancerous Lesions After Treatment of Cervical Lesions in Human Immunodeficiency Virus-infected Women: A Systematic Review and Meta-analysis of Treatment Failure.
    Debeaudrap P; Sobngwi J; Tebeu PM; Clifford GM
    Clin Infect Dis; 2019 Oct; 69(9):1555-1565. PubMed ID: 30602038
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Treatment of pre- and confirmed cervical cancer in HIV-seropositive women from developing countries: a systematic review.
    Mapanga W; Singh E; Feresu SA; Girdler-Brown B
    Syst Rev; 2020 Apr; 9(1):79. PubMed ID: 32276672
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Experience using cryotherapy for treatment of cervical precancerous lesions in low-resource settings.
    Jacob M; Broekhuizen FF; Castro W; Sellors J
    Int J Gynaecol Obstet; 2005 May; 89 Suppl 2():S13-20. PubMed ID: 15823262
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Training for cervical cancer prevention programs in low-resource settings: focus on visual inspection with acetic acid and cryotherapy.
    Blumenthal PD; Lauterbach M; Sellors JW; Sankaranarayanan R
    Int J Gynaecol Obstet; 2005 May; 89 Suppl 2():S30-7. PubMed ID: 15823264
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cervical cancer screening - The challenges of complete pathways of care in low-income countries: Focus on Malawi.
    Cubie HA; Campbell C
    Womens Health (Lond); 2020; 16():1745506520914804. PubMed ID: 32364058
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prevention of cervical cancer in HIV-seropositive women from developing countries through cervical cancer screening: a systematic review.
    Mapanga W; Girdler-Brown B; Feresu SA; Chipato T; Singh E
    Syst Rev; 2018 Nov; 7(1):198. PubMed ID: 30447695
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Screening for cervical neoplasia in an unselected rural Guatemalan population using direct visual inspection after acetic acid application: a pilot study.
    Mathers LJ; Wigton TR; Leonhardt JG
    J Low Genit Tract Dis; 2005 Oct; 9(4):232-5. PubMed ID: 16205195
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Early experiences in integrating cervical cancer screening and treatment into HIV services in Zomba Central Hospital, Malawi.
    Pfaff C; Singano V; Akello H; Amberbir A; Berman J; Kwekwesa A; Matengeni A; Banda V; Msonko J; Speight C; Kabeya BM; van Oosterhout JJ
    Malawi Med J; 2018 Sep; 30(3):211-214. PubMed ID: 30627358
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cervical cancer prevention in countries with the highest HIV prevalence: a review of policies.
    Asangbeh-Kerman SL; Davidović M; Taghavi K; Kachingwe J; Rammipi KM; Muzingwani L; Pascoe M; Jousse M; Mulongo M; Mwanahamuntu M; Tapela N; Akintade O; Basu P; Dlamini X; Bohlius J
    BMC Public Health; 2022 Aug; 22(1):1530. PubMed ID: 35948944
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Expanding the Single-Visit Approach for Cervical Cancer Prevention: Successes and Lessons From Burkina Faso.
    Ouedraogo Y; Furlane G; Fruhauf T; Badolo O; Bonkoungou M; Pleah T; Lankoande J; Bicaba I; Bazant ES
    Glob Health Sci Pract; 2018 Jun; 6(2):288-298. PubMed ID: 29959272
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Assessment of the impact of cotrimoxazole prophylaxis on key outcomes among HIV-infected adults in low- and middle-income countries: a systematic review.
    Saadani Hassani A; Marston BJ; Kaplan JE
    J Acquir Immune Defic Syndr; 2015 Apr; 68 Suppl 3(Suppl 3):S257-69. PubMed ID: 25768865
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Thermo-coagulation versus cryotherapy for treatment of cervical precancers: A prospective analytical study in a low-resource African setting.
    Chigbu CO; Onwudiwe EN; Onyebuchi AK
    J Obstet Gynaecol Res; 2020 Jan; 46(1):147-152. PubMed ID: 31595603
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A systematic review and meta-analysis of thermal coagulation compared with cryotherapy to treat precancerous cervical lesions in low- and middle-income countries.
    de Fouw M; Oosting RM; Rutgrink A; Dekkers OM; Peters AAW; Beltman JJ
    Int J Gynaecol Obstet; 2019 Oct; 147(1):4-18. PubMed ID: 31273785
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cervical screening using visual inspection with acetic acid (VIA) and treatment with cryotherapy in Fiji.
    Fong J; Gyaneshwar R; Lin S; Morrell S; Taylor R; Brassil A; Stuart A; McGowan C
    Asian Pac J Cancer Prev; 2014; 15(24):10757-62. PubMed ID: 25605171
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The Recurrence of Cervical Precancerous Lesion Among HIV Positive and Negative Ethiopian Women After Cryotherapy: A Retrospective Cohort Study.
    Bogale AL; Teklehaymanot T; Ali JH; Kassie GM; Medhin G
    Cancer Control; 2022; 29():10732748221129708. PubMed ID: 36151596
    [TBL] [Abstract][Full Text] [Related]  

  • 38. CRYOTHERAPY FOLLOWING VISUAL INSPECTION WITH ACETIC ACID AND LUGOL'S IODINE (VIA/VILI) IN KHWISERO, WESTERN KENYA: LESSON FROM THE FIELD AFFECTING POLICY AND PRACTICE.
    Ngichabe SK; Muthaura PN; Murungi C; Muyoka J; Omenge E; Muchiri L
    East Afr Med J; 2013 Oct; 90(10):316-23. PubMed ID: 26862641
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Preventing cervical cancer in low-resource settings: how far have we come and what does the future hold?
    Tsu VD; Pollack AE
    Int J Gynaecol Obstet; 2005 May; 89 Suppl 2():S55-9. PubMed ID: 15823268
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Factors associated with recurrence of cervical intraepithelial neoplasia 2+ after treatment among HIV-infected women in Western Kenya.
    Huchko MJ; Leslie H; Maloba M; Bukusi EA; Cohen CR
    J Acquir Immune Defic Syndr; 2014 Jun; 66(2):188-92. PubMed ID: 24662299
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.